Sept 21 (Reuters) - Eli Lilly on Tuesday announced a pact with the European Commission (EC) to supply up to 220,000 doses of its COVID-19 dual antibody cocktail for patients aged 12 years and older who are at a high risk of progressing to severe disease. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Vinay Dwivedi)